Ind-Swift Laboratories Limited's latest marketcap:
As of 07/05/2025, Ind-Swift Laboratories Limited's market capitalization has reached $78.87 M. According to our data, Ind-Swift Laboratories Limited is the 26379th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 78.87 M |
| Revenue (ttm) | 54.25 M |
| Net Income (ttm) | 41.44 M |
| Shares Out | 59.09 M |
| EPS (ttm) | 0.7 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 08/08/2025 |
Ind-Swift Laboratories Limited's yearly market capitalization.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 07/05/2025 | ₹78.87 M | 3.14% | 26379 |
| 12/31/2024 | ₹6.42 B | 4.85% | 25191 |
| 12/29/2023 | ₹6.12 B | 49.1% | 25152 |
| 12/30/2022 | ₹4.1 B | 2.21% | 26929 |
| 12/31/2021 | ₹4.01 B | 9.16% | 27091 |
| 12/31/2020 | ₹3.68 B | 230.44% | 24653 |
| 12/31/2019 | ₹1.11 B | -51.9% | 27365 |
| 12/31/2018 | ₹2.31 B | -33.27% | 23087 |
| 12/29/2017 | ₹3.47 B | 130.96% | 21106 |
| 12/30/2016 | ₹1.5 B | -3.94% | 22906 |
Company Profile
About Ind-Swift Laboratories Limited
Ind-Swift Laboratories Limited, along with its subsidiaries, specializes in the development, manufacturing, and sale of active pharmaceutical ingredients (APIs), intermediates, and formulations. The company operates both in India and internationally, catering to diverse therapeutic needs.
Key Offerings
- APIs & Intermediates: Covers a wide range of therapeutic areas including macrolide antibiotics, cardiovascular, antidiabetic, antipsychotic, and anticancer treatments.
- Reference Standards & Impurities: Provides high-quality standards for compounds such as atorvastatin calcium, azithromycin dihydrate, and rosuvastatin calcium.
- Contract Research & Manufacturing: Offers specialized services for pharmaceutical development and production.
Global Presence
The company exports its products worldwide, ensuring high-quality pharmaceutical solutions reach international markets.
Company Background
Established in 1995, Ind-Swift Laboratories Limited is headquartered in Manimajra, India, and continues to be a trusted name in the pharmaceutical industry.
Frequently Asked Questions
-
What is Ind-Swift Laboratories Limited's (NSE-INDSWFTLAB) current market cap?As of 07/05/2025, Ind-Swift Laboratories Limited (including the parent company, if applicable) has an estimated market capitalization of $78.87 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Ind-Swift Laboratories Limited (NSE-INDSWFTLAB) rank globally by market cap?Ind-Swift Laboratories Limited global market capitalization ranking is approximately 26379 as of 07/05/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.